Johnson Matthey | JMAT

Stock Price
1,919.00
Daily Change
1.00 0.05%
Monthly
9.10%
Yearly
22.62%
Q3 Forecast
1,908.64

Peers Price Chg Day Year Date
Covestro 55.30 -1.00 -1.78% 0.04% Sep/05
Air Liquide 175.38 -0.82 -0.47% 5.52% Sep/06
Arkema 57.35 0.05 0.09% -27.45% Sep/05
Akzo Nobel 60.36 1.26 2.13% 3.71% Sep/06
BASF 43.81 -0.19 -0.43% 0.53% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Croda International 2,465.00 26.00 1.07% -36.27% Sep/05
Givaudan 3,504.00 21.00 0.60% -20.53% Sep/05
Johnson Matthey 1,919.00 1.00 0.05% 22.62% Sep/05
Linde 398.60 -5.80 -1.43% -3.63% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Sika AG 185.40 1.25 0.68% -28.42% Sep/05
Solvay 27.48 0.18 0.66% -11.95% Sep/05
Umicore 13.31 0.07 0.53% 31.13% Sep/05
Venator Materials 175.00 174.99 1,749,900.00% -71.77% Sep/03

Indexes Price Day Year Date
EU600 549 -0.88 -0.16% 8.42% Sep/05

Johnson Matthey traded at 1,919.00 this Friday September 5th, increasing 1.00 or 0.05 percent since the previous trading session. Looking back, over the last four weeks, Johnson Matthey gained 9.10 percent. Over the last 12 months, its price rose by 22.62 percent. Looking ahead, we forecast Johnson Matthey to be priced at 1,908.64 by the end of this quarter and at 1,877.88 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson Matthey Plc is a provider of catalysts and catalyst systems to reduce emissions from vehicles and industry. The Company serves customers in global automotive, chemicals, pharmaceuticals and other industrial markets. The Company delivers its solutions through four global sectors: clean air, efficient natural resources, health and new markets. The clean air segment provides catalysts and technologies that abate emissions. The efficient natural resources segment offers products and processes that conserve and recycle scarce resources using less energy and fewer raw materials to chemicals, energy, transport and healthcare sectors. Health segment provides capabilities in complex chemistry, manufacturing and scale up to create active pharmaceutical ingredients and other solutions for niche areas. Its new market segment is engaged in applying its science into emerging opportunities, such as battery materials and fuel cells in the healthcare, transport, energy and chemicals segment.